Bococizumab is a novel anti-PCSK9 antibody specifically developed to combat hypercholesterolemia. It therapeutic agent works by the PCSK9 protein, a essential regulator of cholesterol concentrations. By neutralizing https://gretaqcbs996223.aboutyoublog.com/profile